Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.86B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
Mercado Libre
MELI
|
+$1.59B |
| 4 |
TSMC
TSM
|
+$1.34B |
| 5 |
Coupang
CPNG
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$2.61B |
| 2 |
EPAM Systems
EPAM
|
+$1.48B |
| 3 |
Twilio
TWLO
|
+$1.35B |
| 4 |
Apple
AAPL
|
+$1.24B |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Healthcare | 9.8% |
| 3 | Financials | 9.16% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5476
XBiotech
XBIT
$75M
| $315K | ﹤0.01% |
36,416
+15,428
| +74% | +$155K |
|
|
ICVX
5477
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $315K | ﹤0.01% |
44,728
+3,494
| +8% | +$54.9K |
|
5478
Comscore
SCOR
$108M
| $314K | ﹤0.01% |
5,399
-2,258
| -29% | -$129K |
|
|
SMMF
5479
DELISTED
Summit Financial Group, Inc.
SMMF
| $313K | ﹤0.01% |
12,216
+699
| +6% | +$18.7K |
|
|
HEXO
5480
DELISTED
HEXO Corp. Common Shares
HEXO
| $313K | ﹤0.01% |
36,042
-708,573
| -95% | -$6.03M |
|
5481
Luxfer Holdings
LXFR
$457M
| $311K | ﹤0.01% |
18,523
+6,425
| +53% | +$114K |
|
|
MTR
5482
Mesa Royalty Trust
MTR
$5.31M
| $311K | ﹤0.01% |
36,090
+2,390
| +7% | +$18.8K |
|
|
EXAI
5483
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $311K | ﹤0.01% |
21,609
-16,218
| -43% | -$276K |
|
|
IMGO
5484
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $311K | ﹤0.01% |
16,114
+7,399
| +85% | +$154K |
|
5485
iShares Russell 2500 ETF
SMMD
$3.77B
| $310K | ﹤0.01% |
4,975
+540
| +12% | +$33.2K |
|
5486
WisdomTree New Economy Real Estate Fund
WTRE
$16.1M
| $310K | ﹤0.01% |
13,411
-9,501
| -41% | -$224K |
|
5487
Q32 Bio
QTTB
$458M
| $310K | ﹤0.01% |
5,660
-9,682
| -63% | -$601K |
|
5488
Park-Ohio Holdings
PKOH
$716M
| $309K | ﹤0.01% |
21,954
-1,204
| -5% | -$21.7K |
|
5489
Sigma Lithium
SGML
$1.27B
| $309K | ﹤0.01% |
22,739
+22,489
| +8,996% | +$246K |
|
|
SEEL
5490
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $309K | ﹤0.01% |
96
+7
| +8% | +$30.1K |
|
5491
Ardmore Shipping
ASC
$681M
| $308K | ﹤0.01% |
68,366
+6,526
| +11% | +$25.6K |
|
5492
National Healthcare
NHC
$3.47B
| $307K | ﹤0.01% |
4,383
-945
| -18% | -$63.6K |
|
|
PSTL
5493
Postal Realty Trust
PSTL
$701M
| $307K | ﹤0.01% |
18,272
-21,409
| -54% | -$381K |
|
5494
CPS Technologies
CPSH
$83M
| $306K | ﹤0.01% |
58,789
-47,324
| -45% | -$162K |
|
5495
KULR Technology Group
KULR
$137M
| $306K | ﹤0.01% |
17,597
+16
| +0.1% | +$297 |
|
|
CND
5496
DELISTED
Concord Acquisition Corp.
CND
| $306K | ﹤0.01% |
30,749
-57,167
| -65% | -$573K |
|
|
HMTV
5497
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $306K | ﹤0.01% |
67,167
+953
| +1% | +$5.73K |
|
|
DRD
5498
DRDGold
DRD
$2.06B
| $305K | ﹤0.01% |
32,686
+19,444
| +147% | +$173K |
|
5499
Ardelyx
ARDX
$1.01B
| $304K | ﹤0.01% |
285,073
-1,544,775
| -84% | -$1.38M |
|
|
GNFT
5500
DELISTED
Genfit
GNFT
| $304K | ﹤0.01% |
75,929
-3,300
| -4% | -$13.5K |
|
Similar funds
Morgan Stanley's Q1 2022 Portfolio in Review
As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
- Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
- Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
- Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
- Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
- Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
- Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.